Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: AMRN, HTGM, SQ, TNDM

Published 09/26/2018, 12:20 AM
Updated 07/09/2023, 06:31 AM

Aon marin Corporation plc (NASDAQ:AMRN) popped 60 cents, or 4.84%, to 13.00, on 106 million shares on Tuesday, which is huge volume for this stock. It traded more than 264 million shares just in two sessions. I put a swing on it Tuesday morning, and I like the way it looks. It popped all the way up to 14.64 before it backed off. When you get a breakaway gap and it doesn’t pull back, let it back and fill. Even though my targets are 15 and 18, I think we’re looking at 21.

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) gained 19 cents, or 4.29%, to 4.62, on 603,741 shares traded on Tuesday. After a base, breakout, 5-wave move, double-top, breakdown, 3-wave corrective pullback, and now 4 waves up with the fifth wave underway, which should take it to retest the double-top around 5.70, and the secondary target at 7 1/2.

Square, Inc. (NYSE:SQ) jumped 9.31, or 11%, to 95.35, on 28 million shares on Tuesday. That’s the biggest volume in a year and is doing its thing again. It had a big day on Tuesday on an introduction to a new payment system that’s in competition with many competitors. Wall Street loved it. I’m looking for this to extend to the 102-3-4 range going forward.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has had quite a move, going from 2.00, and change, in Feb/Mar to over 50. It pulled back, held the trendline, and on Tuesday it popped 3.31, or 7.4%, to 47.84, on 6.2 million shares. If it continues at this angle, the next projected top will be somewhere around 62.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stocks on the long side included ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Applied Genetic Technologies Corporation (NASDAQ:AGTC), Amarin Corporation plc (NASDAQ:AMRN), Amyris, Inc. (NASDAQ:AMRS), Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Bloom Energy Corporation (NYSE:BE), Canopy Growth Corporation (NYSE:CGC), Cleveland-Cliffs Inc. (NYSE:CLF), iShares MSCI Brazil ETF USD Acc (NASDAQ:CSBR), HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), Iridium Communications Inc. (NASDAQ:IRDM), IRadimed Corporation (NASDAQ:IRMD), NovoCure Limited (NASDAQ:NVCR), Planet Fitness, Inc. (NYSE:PLNT), Square, Inc. (NYSE:SQ), Teladoc, Inc. (NYSE:TDOC), Talend S.A. (NASDAQ:TLND), Tandem Diabetes Care, Inc. (NASDAQ:TNDM), Twilio Inc. (NYSE:TWLO), Unisys Corporation (NYSE:UIS). W&T Offshore, Inc. (NYSE:WTI), and Zafgen, Inc. (NASDAQ:ZFGN).

Latest comments

thought on amd into earnings? 40$....maybe
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.